![Hong Sheng Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hong Sheng Xu
Amministratore Delegato presso Shapuaisi Qiangshen Pharma Co., Ltd.
Posizioni attive di Hong Sheng Xu
Società | Posizione | Inizio | Fine |
---|---|---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
![]() Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - |
Storia della carriera di Hong Sheng Xu
Precedenti posizioni note di Hong Sheng Xu
Società | Posizione | Inizio | Fine |
---|---|---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Direttore/Membro del Consiglio | 25/09/2018 | - |
Presidente | 25/09/2018 | - |
Statistiche
Distribuzione geografica
Cina | 3 |
Posizioni
Director/Board Member | 2 |
Chairman | 1 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Health Technology |
Aziende private | 1 |
---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
![]() Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Health Technology |
- Borsa valori
- Insiders
- Hong Sheng Xu
- Esperienza